LncRNA LINC01133 Targeting miR-141-5p to Mediate the Progression and Ameliorate Poor Prognosis of Prostate Cancer
-
Published:2023-12
Issue:S2
Volume:59
Page:S191-S198
-
ISSN:1022-7954
-
Container-title:Russian Journal of Genetics
-
language:en
-
Short-container-title:Russ J Genet
Author:
Li Y. Y.,Zhang Y. N.
Publisher
Pleiades Publishing Ltd
Reference23 articles.
1. Wang, K.Y., Wang, K.J., and Ma, Q., The expression and significance of p4E-BP1/4E-BP1 in prostate cancer, J. Clin. Lab. Anal., 2022, vol. 36, no. 4, p. e24332. 2. Sung, H., Ferlay, J., Siegel, R.L., et al., Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 2021, vol. 71, no. 3, pp. 209—249. 3. Okidi, R., Opira, C., Sambo, V.D.C., et al., Prostate hyperplasia in St Mary’s Hospital Lacor: utility of prostate specific antigen in screening for prostate malignancy, Afr. Health Sci., 2020, vol. 20, no. 3, pp. 1259—1263. 4. Ried, K., Tamanna, T., Matthews, S., et al., New screening test improves detection of prostate cancer using circulating tumor cells and prostate-specific markers, Front. Oncol., 2020, vol. 10, p. 582. 5. Jomoto, W., Tanooka, M., Doi, H., et al., Development of a three-dimensional surgical navigation system with magnetic resonance angiography and a three-dimensional printer for robot-assisted radical prostatectomy, Cureus., 2018, vol. 10, no. 1, p. e2018.
|
|